Agents for preventing and treating disorders involving modulation of the RyR receptors

Details for Australian Patent Application No. 2006283534 (hide)

Owner The Trustees of Columbia University in the City of New York

Inventors Deng, Shixian; Cheng, Zhen Zhuang; Lehnart, Stephan E.; Landry, Donald W.; Marks, Andrew Robert

Agent Spruson & Ferguson

Pub. Number AU-B-2006283534

PCT Pub. Number WO2007/024717

Priority 11/212,413 25.08.05 US

Filing date 17 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 4 November 2010

International Classifications

C07D 281/02 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/024717 Priority application(s): WO2007/024717

4 November 2010 Application Accepted

  Published as AU-B-2006283534

3 March 2011 Standard Patent Sealed

29 March 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 14 Oct 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

2 August 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 14 Oct 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283551-Ultrawideband antenna for operation in tissue

2006283532-Dual variable domain immunoglobin and uses thereof